Researchers analyze the values and preferences of patients and their caregivers when being treated for atopic dermatitis.
The Boxed Warning Toolkit, a brand-new session at the 2023 South Beach Symposium (SBS) was led by Christopher G. Bunick, MD, PhD
The 2023 SBS featured an in-depth session covering Anti-Aging and Integrative Medicine, including the role of nutrients in skin health.
The 2023 South Beach Symposium (SBS) included a brand-new hot topic, Applications of Genomics and How It Impacts Patient Care.
Recent phase three clinical trial shows topical gene therapy (B-VEC) help over half of patients see complete wound closure after six months.
Dr. Christopher Bunick discusses precision medicine, examining the role of genomics and personalized care for patients at SBS 2023.
The 2023 South Beach Symposium (SBS) ended on Sunday, Feb. 12, after four incredible days of learning, discovery and networking.
The 31st Annual Masters of Pediatric Dermatology (MOPD) Symposium came to an end on Friday, Feb. 10. Here’s what you need to know!
Today was the final day of SBS 2023! We are sad to say goodbye but are thrilled at having spent an eventful four days with all of you.
Day Three of the South Beach Symposium (SBS) featured a jam-packed agenda, including two dedicated specialty sessions.
Here is a recap of Day Two of the exciting South Beach Symposium (SBS) live from the Loews Resort in Miami Beach.
The South Beach Symposium (SBS) has officially kicked off. Here are the highlights from Day One of the conference.
Dr. Karan Lal recently discussed his experience treating Epidermolysis Bullosa (EB), a rare genetic skin disorder.
The American Academy of Dermatology has published updated guidelines for the care and management of atopic dermatitis.
Arcutis Biotherapeutics has submitted a Supplemental New Drug Application to the FDA for the expanded indication of Zoryve cream for plaque psoriasis.
Patricia K. Farris, MD recently shared some insight into the topics she will be covering at South Beach Symposium 2023.
The fast-track designation is for the clinical study of the plasmid DNA vaccine ITI-3000 in patients with Merkel cell carcinoma.
Accure Acne, Inc. announced the FDA had cleared their Accure Laser™ System for treating mild-to-severe inflammatory acne vulgaris.
Results from a nonrandomized clinical trial suggest that apremilast (Otezla), may have cardiometabolic health benefits for patients with psoriasis.
The FDA approved ellacor System uses micro-coring technology (MCT) to treat facial wrinkles and tightening.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
LiVDerm / South Beach Symposium
1801 N Military Trail, Ste 110
Boca Raton, FL, 33431
Copyright © 2025, LiVDerm. All Rights Reserved.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
Sign up to receive updates on educational opportunities, complimentary content, exclusive discounts, and more.
